Breast Cancer Trends in Women in Sweden, the UK, and the USA in Relation to Their Past Use of Oral Contraceptives

  • Valerie Beral
  • Carol Hermon
  • Gillian Reeves
  • Timothy Key


Since their introduction in the early 1960’s, oral contraceptives (OCs) have become one of the most popular methods of contraception. They have been used by an estimated 67 million women in developed countries and 200 million women worldwide (International Planned Parenthood Federation, personal communication). Reports that OC use might increase the risk of breast cancer came first from California (1), and subsequently from Sweden and Norway (2), the UK (3), and elsewhere in the USA (4). However, the results of many other studies, particularly those that included older women, did not suggest an increase in breast cancer risk (5). Nevertheless, some have expressed concern that the use of OCs at an early age, especially before the birth of the first child, may lead to an increase in the risk of breast cancer when women reach middle-age (6).


Breast Cancer Breast Cancer Risk Oral Contraceptive Breast Cancer Mortality Mortality Trend 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Pike MC, Henderson BE, Krailo MD et al (1983) Breast cancer in young women and use of oral contraceptives. Possible modifying effects of formulation and age at use. Lancet II: 926–930.CrossRefGoogle Scholar
  2. 2.
    Meirik O, Adami H-O, Christoffersen T et al (1986) Oral contraceptive use and breast cancer in young women. Lancet II: 650–653.CrossRefGoogle Scholar
  3. 3.
    UK National Case-Control Study Group (1989) Oral contraceptive use and breast cancer risk in young women. Lancet I: 973–982.Google Scholar
  4. 4.
    White E, Malone KE, Weiss NS, Daling JR (1994) Breast cancer among young US women in relation to oral contraceptive use. J Natl Cancer Inst 86: 505–514.PubMedCrossRefGoogle Scholar
  5. 5.
    Wingo PA, Lee NC, Ory HW et al (1991) Age-specific differences in the relationship between oral contraceptive use and breast cancer. Obst Gynecol 78: 161–170.Google Scholar
  6. 6.
    McPherson K (1993) Childbearing, oral contraceptive use and breast cancer. Lancet 341: 1604.PubMedCrossRefGoogle Scholar
  7. 7.
    Lund E, Meirik O, Adami H-0 et al (1989) Oral contraceptive use and premenopausal breast cancer in Sweden and Norway: Possible effects of different pattern of use. Int J Epidemiology 18: 527–532.CrossRefGoogle Scholar
  8. 8.
    Thorogood M, Vessey MP (1990) Trends in use of oral contraceptives in Britain. Brit J Family Planning 16: 41–53.Google Scholar
  9. 9.
    Werner B, Chalk S (1986) Projections of first, second, third and later births. Population Trends 45: 26–34.Google Scholar
  10. 10.
    Tarone RE, Chu KC (1992) Implications of birth cohort patterns in interpreting trends in breast cancer rates. J Natl Cancer Inst 84: 1402–1410.PubMedCrossRefGoogle Scholar
  11. 11.
    Early Breast Cancer Trialists’ Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339: 1–15.Google Scholar
  12. 12.
    Doll R, Peto R (1981) The causes of cancer. J Natl Cancer Inst 66: 1191–1308.PubMedGoogle Scholar
  13. 13.
    Peto R, Lopez AD, Boreham J et al (1994) Mortality from smoking in developed countries 1950–2000. Oxford University Press. Oxford.Google Scholar

Copyright information

© Springer-Verlag New York, Inc. 1996

Authors and Affiliations

  • Valerie Beral
  • Carol Hermon
  • Gillian Reeves
  • Timothy Key

There are no affiliations available

Personalised recommendations